By Counterforce Health Team in Voydeya (danicopan) —

Get Voydeya (Danicopan) Approved by UnitedHealthcare in North Carolina: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Voydeya Covered by UnitedHealthcare in North Carolina

Voydeya (danicopan) requires prior authorization from UnitedHealthcare for coverage as an add-on therapy to C5 inhibitors (eculizumab or ravulizumab) in adults with paroxysmal nocturnal hemoglobinuria (PNH) experiencing extravascular hemolysis. Your fastest path to approval: Have your hematologist submit a prior authorization through the UnitedHealthcare Provider Portal with documentation of confirmed PNH diagnosis by flow cytometry, current C5 inhibitor therapy, and evidence of ongoing extravascular hemolysis despite treatment. If denied, you can appeal internally (typically 86% success rate) and through North Carolina's Smart NC external review program within 120 days.

Table of Contents

  1. Coverage Basics
  2. Prior Authorization Process
  3. Timeline and Urgency
  4. Medical Necessity Criteria
  5. Cost Considerations
  6. Denials and Appeals
  7. Renewal Requirements
  8. Specialty Pharmacy Network
  9. Troubleshooting Common Issues
  10. Frequently Asked Questions

Coverage Basics

Is Voydeya Covered by UnitedHealthcare?

Yes, Voydeya (danicopan) is covered by UnitedHealthcare plans but requires prior authorization through OptumRx. The medication is approved as add-on therapy to complement C5 inhibitors for treating extravascular hemolysis in adults with PNH.

Coverage Requirements at a Glance:

Requirement Details Documentation Needed
Diagnosis Confirmed PNH by flow cytometry Lab results, diagnostic reports
Current Treatment Must be on eculizumab or ravulizumab Prescription records, treatment history
Medical Necessity Evidence of EVH despite C5 therapy Hemoglobin levels, reticulocyte count, transfusion records
Prescriber Hematologist or specialist Provider credentials verification
Plan Type Fully insured commercial plans covered by NC external review Check with benefits administrator

Source: UnitedHealthcare Voydeya Prior Authorization Policy

Which UnitedHealthcare Plans Cover Voydeya?

Most UnitedHealthcare commercial plans include Voydeya coverage with prior authorization. However, coverage specifics vary by plan type:

  • Fully insured commercial plans: Subject to North Carolina insurance regulations and external review rights
  • Self-funded employer plans: May have different appeal processes
  • Medicare Advantage: Covered with prior authorization; expedited appeals available for urgent cases

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. Verify Coverage (Patient/Clinic): Check member portal or call member services to confirm prior authorization requirement
  2. Gather Documentation (Clinic): Collect PNH diagnosis confirmation, current C5 inhibitor therapy records, and EVH evidence
  3. Submit PA Request (Provider): Use UnitedHealthcare Provider Portal or PreCheck MyScript tool
  4. Include Required Evidence (Provider): Upload medical necessity documentation per UnitedHealthcare criteria
  5. Track Status (Provider/Patient): Monitor through provider portal or call OptumRx at 1-800-711-4555
  6. Follow Up (All): Respond promptly to any requests for additional information
  7. Appeal if Denied (All): Submit internal appeal within required timeframe if initial request is denied
Tip: UnitedHealthcare's PreCheck Prior Authorization system may provide automated approval in under 30 seconds for eligible requests with complete documentation.

Timeline and Urgency

Standard Processing Times

  • Initial PA Decision: Typically 72 hours for standard requests
  • Automated Approvals: Median 29 seconds through PreCheck system when eligible
  • Additional Information Requests: 14 days to respond to insurer requests
  • Internal Appeals: 30 days for standard, 72 hours for expedited

When to Request Expedited Review

Request expedited processing if:

  • Patient requires immediate treatment due to severe anemia or transfusion dependence
  • Delay would seriously jeopardize health or ability to regain function
  • Current C5 inhibitor therapy is failing to control hemolysis adequately

For urgent cases in North Carolina: You can request expedited external review through Smart NC if internal appeals are insufficient, with decisions required within 72 hours.

Medical Necessity Criteria

Clinician Corner: Medical Necessity Documentation

Essential Elements for Approval:

✓ Confirmed PNH Diagnosis: Flow cytometry results showing complement-mediated hemolysis
✓ Current C5 Inhibitor Therapy: Documentation of eculizumab or ravulizumab treatment
✓ Evidence of EVH: Laboratory values showing ongoing hemolysis despite C5 therapy
✓ Treatment History: Prior therapies attempted and clinical outcomes
✓ Specialist Care: Prescription from qualified hematologist or PNH specialist

Key Laboratory Values to Include:

  • Hemoglobin levels and trends
  • Reticulocyte count
  • LDH levels
  • Transfusion requirements
  • Flow cytometry results

Clinical Guidelines Reference: Base medical necessity on FDA-approved indication and established PNH treatment protocols.

What UnitedHealthcare Looks For

According to UnitedHealthcare's medical policy, approval requires:

  • Documented PNH diagnosis confirmed by appropriate testing
  • Current treatment with eculizumab or Ultomiris (ravulizumab)
  • Clinical evidence of extravascular hemolysis while on C5 inhibitor therapy
  • Exclusion of contraindicated combinations (not with Empaveli or Fabhalta)

Source: UnitedHealthcare Voydeya Medical Necessity Policy

Cost Considerations

Understanding Your Financial Responsibility

Voydeya's estimated annual cost ranges from $50,000-$100,000, making financial planning crucial:

Typical Coverage Structure:

  • Formulary Tier: Specialty tier (highest copay/coinsurance)
  • Copay vs. Coinsurance: Most plans use percentage-based coinsurance for specialty drugs
  • Annual Out-of-Pocket Maximum: Applies to reduce total yearly costs

Savings and Support Options

Manufacturer Support:

  • Alexion may offer patient assistance programs
  • Check Voydeya.com for current copay assistance eligibility

Additional Resources:

  • North Carolina pharmaceutical assistance programs
  • Disease-specific foundations offering grants
  • Hospital charity care programs for qualifying patients
Note: Copay assistance programs may not apply to government insurance plans (Medicare, Medicaid).

Denials and Appeals

Common Denial Reasons and Solutions

Denial Reason How to Address Required Documentation
Insufficient medical necessity Provide comprehensive clinical evidence Updated labs, treatment response data
Missing C5 inhibitor documentation Submit current prescription records Pharmacy records, infusion center notes
Lack of specialist prescriber Transfer care to hematologist New prescription from qualified specialist
Incomplete vaccination records Document required immunizations Vaccination records per REMS requirements

Appeals Process for UnitedHealthcare in North Carolina

Internal Appeals (Required First Step):

  1. Level 1: Submit within 180 days of denial notice
  2. Level 2: Available if Level 1 is denied
  3. Expedited Appeals: 72-hour decision for urgent cases

External Review Through Smart NC:

  • Eligibility: Available after exhausting internal appeals for fully insured plans
  • Timeline: Submit within 120 days of final internal denial
  • Process: Independent clinical review by qualified specialists
  • Success Rate: North Carolina external reviews have historically favorable overturn rates

How to File External Review:

  1. Complete External Review Request Form
  2. Include all medical records and denial correspondence
  3. Submit to Smart NC within 120-day deadline
  4. Provide additional evidence within 7 days if case is accepted

Contact Smart NC: 855-408-1212

Scripts for Common Situations

Patient Phone Script for UnitedHealthcare: "I'm calling about a prior authorization denial for Voydeya (danicopan) for my PNH treatment. I'd like to understand the specific reasons for denial and the appeals process. My member ID is [number] and the denial reference is [number]."

Clinic Staff Peer-to-Peer Request: "We're requesting a peer-to-peer review for Voydeya prior authorization denial. Our patient has documented PNH with ongoing extravascular hemolysis despite optimized C5 inhibitor therapy. When can we schedule a clinical discussion?"

Renewal Requirements

When Reauthorization is Needed

UnitedHealthcare typically approves Voydeya for 12-month periods with reauthorization required for continued coverage.

Renewal Documentation Requirements:

  • Updated clinical assessment showing continued medical necessity
  • Laboratory results demonstrating ongoing treatment response
  • Confirmation of continued C5 inhibitor therapy
  • Assessment of any adverse effects or treatment modifications

Timing Your Renewal

Submit reauthorization requests 30-60 days before expiration to avoid treatment interruptions. Most renewals are streamlined if clinical status remains stable.

Specialty Pharmacy Network

Why Voydeya May Be Transferred

UnitedHealthcare often requires specialty medications like Voydeya to be dispensed through their preferred specialty pharmacy network for:

  • Enhanced clinical monitoring and support
  • Cost management and rebate optimization
  • REMS program compliance oversight
  • Coordinated care with your treatment team

OptumRx Specialty Pharmacy is typically the preferred network pharmacy for UnitedHealthcare members requiring Voydeya.

Troubleshooting Common Issues

Portal and System Problems

If the UnitedHealthcare Provider Portal is Down:

  • Call OptumRx Prior Authorization: 1-800-711-4555
  • Fax requests to number provided in most recent denial letter
  • Use backup submission methods outlined in provider manual

Missing Forms or Documentation:

  • Download current forms from UnitedHealthcare Provider Resources
  • Contact member services to verify required documentation
  • Request expedited processing if delays affect patient care

When to Contact North Carolina Regulators

File a complaint with the North Carolina Department of Insurance if:

  • UnitedHealthcare fails to respond within required timeframes
  • Appeals process is not followed correctly
  • External review rights are improperly denied

NC Department of Insurance Consumer Services: 855-408-1212

Frequently Asked Questions

Q: How long does UnitedHealthcare prior authorization take for Voydeya in North Carolina? A: Standard requests typically receive decisions within 72 hours. Automated approvals through PreCheck may occur in under 30 seconds with complete documentation.

Q: What if Voydeya is not on my UnitedHealthcare formulary? A: Non-formulary medications can still be covered with prior authorization demonstrating medical necessity. Appeals may be needed for coverage at preferred tier levels.

Q: Can I request an expedited appeal for Voydeya denial? A: Yes, expedited appeals are available for urgent medical situations. UnitedHealthcare must respond within 72 hours for expedited requests.

Q: Does step therapy apply if I failed treatments outside North Carolina? A: Treatment history from other states is typically accepted if properly documented. Ensure all prior therapy records are included in your prior authorization request.

Q: What happens if my employer plan is self-funded? A: Self-funded plans may not be subject to North Carolina external review laws but often have similar independent review processes. Check your plan documents or contact your benefits administrator.

Q: How do I know if my UnitedHealthcare plan is fully insured or self-funded? A: Check your insurance card or plan documents for "insured by" language, or contact member services. Self-funded plans often state they are "administered by" rather than "insured by" UnitedHealthcare.

Q: Can I appeal directly to Smart NC without internal appeals? A: Generally no, unless you qualify for expedited review due to urgent medical circumstances. Internal appeals must typically be exhausted first.

Q: What if I need Voydeya while traveling outside North Carolina? A: UnitedHealthcare coverage typically follows you nationwide. Ensure your specialty pharmacy can coordinate shipments or temporary supplies for travel.

Counterforce Health helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements and turn insurance denials into successful appeals. Our platform analyzes denial letters, identifies specific coverage criteria, and drafts evidence-backed appeals that address payer requirements point-by-point. For patients facing Voydeya denials, we provide targeted support that aligns clinical documentation with UnitedHealthcare's specific approval criteria, improving the likelihood of coverage approval.

When dealing with UnitedHealthcare denials for specialty medications like Voydeya, having expert support can make the difference between prolonged treatment delays and timely access to necessary care. Counterforce Health specializes in transforming complex medical evidence into compelling appeals that speak directly to payer requirements.

From our advocates: "We've seen PNH patients successfully overturn Voydeya denials by strengthening the connection between their ongoing hemolysis symptoms and the FDA-approved indication for add-on therapy. The key is often providing more detailed laboratory trending data that clearly shows extravascular hemolysis persisting despite optimized C5 inhibitor therapy. This composite experience reflects multiple cases but doesn't guarantee individual outcomes."

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual plan terms and clinical circumstances. Always consult with your healthcare provider about treatment decisions and contact your insurance company or the North Carolina Department of Insurance for specific coverage questions. For personalized assistance with prior authorizations and appeals, consider consulting with Counterforce Health or similar advocacy services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.